| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | CANN GROUP LIMITED: Cann announces FY25 half year results | 1 | ASX | ||
| Fr | CANN GROUP LIMITED: Appendix 4D and Half Year Report | 3 | ASX | ||
| CANN GROUP Aktie jetzt für 0€ handeln | |||||
| 30.01. | CANN GROUP LIMITED: Quarterly Activities/Appendix 4C Cash Flow Report | 2 | ASX | ||
| 18.01. | CANN GROUP LIMITED: Change in substantial holding | - | ASX | ||
| 09.01. | CANN GROUP LIMITED: Change in substantial holding | - | ASX | ||
| 08.01. | CANN GROUP LIMITED: Application for quotation of securities - CAN | - | ASX | ||
| 05.01. | CANN GROUP LIMITED: Becoming a substantial holder | - | ASX | ||
| 24.12.25 | CANN GROUP LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 24.12.25 | CANN GROUP LIMITED: Top 20 Option Holders & Distribution Schedule | - | ASX | ||
| 24.12.25 | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
| 24.12.25 | CANN GROUP LIMITED: Application for quotation of securities - CAN | - | ASX | ||
| 23.12.25 | CANN GROUP LIMITED: Application for quotation of securities - CAN | 1 | ASX | ||
| 23.12.25 | CANN GROUP LIMITED: Results of EGM | - | ASX | ||
| 21.12.25 | CANN GROUP LIMITED: Target Market Determination | - | ASX | ||
| 21.12.25 | CANN GROUP LIMITED: Prospectus | - | ASX | ||
| 14.12.25 | CANN GROUP LIMITED: Cann Successfully Completes Debt Restructure | 2 | ASX | ||
| 10.12.25 | CANN GROUP LIMITED: Change of Director's Interest Notice x 3 | - | ASX | ||
| 09.12.25 | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
| 09.12.25 | CANN GROUP LIMITED: Notification regarding unquoted securities - CAN | - | ASX | ||
| 09.12.25 | CANN GROUP LIMITED: Application for quotation of securities - CAN | - | ASX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 39,005 | -3,95 % | MustGrow Biologics und die Partnerschaft mit Bayer: Darum steht die Aktie erst am Anfang | Die globale Landwirtschaft steht vor einem Paradox. Sie muss mehr Menschen ernähren, aber mit weniger chemischen Mitteln. Weltweit sind in 162 Ländern inzwischen 460 Pestizide verboten oder eingeschränkt.... ► Artikel lesen | |
| NOVO NORDISK | 31,500 | -2,08 % | Hims & Hers nach Preisattacke auf Novo Nordisk mit Zahlen: Aktie rauscht erneut in den Keller | Die US-amerikanische Telemedizin-Plattform Hims & Hers hat am Montag nach Börsenschluss die Zahlen für das vierte Quartal respektive Gesamtjahr 2025 vorgelegt. Überschattet werden die Ergebnisse und... ► Artikel lesen | |
| AURORA CANNABIS | 3,065 | -3,92 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| ABBVIE | 201,50 | +0,50 % | AbbVie Reports Positive Phase 3 Results For Risankizumab In Crohn's Disease | WASHINGTON (dpa-AFX) - AbbVie (ABBV) on Monday announced positive results from the Phase 3 AFFIRM study evaluating subcutaneous risankizumab in moderately to severely active Crohn's disease.... ► Artikel lesen | |
| CANOPY GROWTH | 0,906 | -2,48 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,460 | -0,77 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| VERTEX PHARMACEUTICALS | 414,00 | -0,46 % | Vertex Pharmaceuticals Inc. Reports Rise In Q4 Bottom Line | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last yearThe company's earnings came in at $1.191 billion... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 37,850 | -4,54 % | Dermapharm: Spannend für langfristig orientierte Investoren | Am 17. März wird Dermapharm Zahlen für 2025 präsentieren. Erwartet wird von Dermapharm ein Umsatz von 1,16 Milliarden Euro bis 1,2 Milliarden Euro. Das bereinigte EBITDA sieht die Gesellschaft bei 322... ► Artikel lesen | |
| CRONOS GROUP | 2,294 | +1,77 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | -8,33 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,180 | +3,51 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| GREEN THUMB INDUSTRIES | 5,335 | -1,57 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,281 | -1,00 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,823 | +3,92 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen |